WEBBiogen has discontinued the commercialization and sale of ADUHELM. Patients currently prescribed and taking ADUHELM will be eligible for continued dosing until November 1, 2024. ADUHELM will no longer be available for purchase after November 1, 2024.*
WEBDo 4 more brain scans, before your 5th, 7th, 9th, and 12th infusions of ADUHELM, to check for ARIA. Decide if you should have more brain scans, particularly as your doses increase in the first 8 months of treatment. Do these brain scans by …
WEBINDICATION. ADUHELM is indicated for the treatment of Alzheimer’s disease. ADUHELM should be started in patients with mild cognitive impairment or mild dementia stage of disease, the population studied in clinical trials.
WEBBiogen Support Services for Patients 1-833-425-9360. About ADUHELM Safety and Side Effects Biogen Support Services for Patients Biogen Support Services for Patients 1-833-425-9360. Prescribing Information; Medication Guide; Important Safety Information; View Healthcare Professionals Site ...
WEBADUHELM is indicated for the treatment of Alzheimer’s disease. ADUHELM should be started in patients with mild cognitive impairment or mild dementia stage of disease, the population studied in clinical trials.